Drug Use Surveillance of Takecab for " Supplement to Helicobacter Pylori Eradication "
Condition: Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other Interventions: Drug: Vonoprazan; Drug: Amoxicillin hydrate; Drug: Clarithromycin; Drug: Metronidazole Sponsor: Takeda Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials
Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition: Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention: Drug: Vonoprazan Sponsor: Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials
Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition: A History of Gastric or Duodenal Ulcers Intervention: Drug: Vonoprazan Sponsor: Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials
Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition: Gastric or Duodenal Ulcers Intervention: Drug: Vonoprazan Sponsor: Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials
Drug Use Surveillance of Takecab for " Supplement to Helicobacter Pylori Eradication "
Condition: Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other Interventions: Drug: Vonoprazan; Drug: Amoxicillin hydrate; Drug: Clarithromycin; Drug: Metronidazole Sponsor: Takeda Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials
Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition: Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention: Drug: Vonoprazan Sponsor: Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials
Drug Use Surveillance of Takecab for " Supplement to Helicobacter Pylori Eradication "
Condition: Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other Interventions: Drug: Vonoprazan; Drug: Amoxicillin hydrate; Drug: Clarithromycin; Drug: Metronidazole Sponsor: Takeda Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
Condition: Duodenal Ulcer Interventions: Drug: TAK-438; Drug: Lansoprazole; Drug: TAK-438 Placebo; Drug: Lansoprazole Placebo; Drug: Bismuth-Containing Quadruple Therapy Sponsor: Takeda Not yet recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2017 Category: Research Source Type: clinical trials
